Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gordon

Showing results (931-940 of 1,032) with videos related to

Pageof 104
Sort By:
British Journal of Haematology|October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes databaseMakiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Cancer|April 8, 2014
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer NetworkAlex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, et al.
Cell|June 28, 2022
Microbial liberation of N-methylserotonin from orange fiber in gnotobiotic mice and humansNathan D Han, Jiye Cheng, Omar Delannoy-Bruno, et al.
Nature|June 5, 2014
Persistent gut microbiota immaturity in malnourished Bangladeshi childrenSathish Subramanian, Sayeeda Huq, Tanya Yatsunenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2025
CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosisSophia M Lamperis, Kaylin M McMahon, Andrea E Calvert, et al.
Cell Reports|March 29, 2018
Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus InfectionsLarissa B Thackray, Scott A Handley, Matthew J Gorman, et al.
British Journal of Haematology|March 18, 2014
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphomaRyan D Gentzler, Andrew M Evens, Alfred W Rademaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2022
An approach for evaluating the effects of dietary fiber polysaccharides on the human gut microbiome and plasma proteomeOmar Delannoy-Bruno, Chandani Desai, Juan J Castillo, et al.
Blood Advances|July 24, 2025
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and EfficacyOluwatobi Odetola, Shuo Ma, Jane N Winter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphomaJane N Winter, David J Inwards, Stewart Spies, et al.
Pageof 104

Showing results (931-940 of 1,032) with videos related to

Sort By:
Pageof 104
British Journal of Haematology|October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes databaseMakiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Cancer|April 8, 2014
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer NetworkAlex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, et al.
Cell|June 28, 2022
Microbial liberation of N-methylserotonin from orange fiber in gnotobiotic mice and humansNathan D Han, Jiye Cheng, Omar Delannoy-Bruno, et al.
Nature|June 5, 2014
Persistent gut microbiota immaturity in malnourished Bangladeshi childrenSathish Subramanian, Sayeeda Huq, Tanya Yatsunenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2025
CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosisSophia M Lamperis, Kaylin M McMahon, Andrea E Calvert, et al.
Cell Reports|March 29, 2018
Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus InfectionsLarissa B Thackray, Scott A Handley, Matthew J Gorman, et al.
British Journal of Haematology|March 18, 2014
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphomaRyan D Gentzler, Andrew M Evens, Alfred W Rademaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2022
An approach for evaluating the effects of dietary fiber polysaccharides on the human gut microbiome and plasma proteomeOmar Delannoy-Bruno, Chandani Desai, Juan J Castillo, et al.
Blood Advances|July 24, 2025
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and EfficacyOluwatobi Odetola, Shuo Ma, Jane N Winter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphomaJane N Winter, David J Inwards, Stewart Spies, et al.
Pageof 104